Monkeypox - 8 Studies Found

Recruiting : IMVAMUNE® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo
: Monkeypox Virus Infection
: 2016-09-07
: Biological: IMVAMUNE® Two doses of attenuated live virus smallpox vaccine (IMVAMUNE®) administ
Available : Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
:
  • Smallpox
  • Monkeypox

: 2014-03-04
: Drug: Tecovirimat Oral tablet 600mg daily dose(three capsules, 200 mg/capsule)
Completed : Phase I Trial of an Investigational Small Pox Medication
:
  • Orthopoxviral Disease
  • Smallpox
  • Monke
    : 2008-08-01
    :
    • Drug: ST-246 Days 1 - 3 First

Completed : A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
:
  • Male or Female Patients With a Serious or Immediately Life-threatening
  • Disease or Condition
    : 2010-06-11
    : Drug: CMX001 CMX001 administered orally twice weekly for up to 3 months. Treatment may be extended for u
Withdrawn : SIGA-246 to Treat Smallpox
: Vaccinia
: 2006-03-14
: Drug: Vaccine: SIGA-246
RECRUITING : A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines
: Monkeypox
: 2024-11-21
: Multivalent ribonucleic acid (RNA)-based vaccine for active immunization against monkeypox administered as intramuscular injection
ACTIVE_NOT_RECRUITING : A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox
: Monkeypox
: 2024-11-21
: JYNNEOS is FDA-approved and licensed as a smallpox and monkeypox vaccine in the United States.JYNNEOS is a live vaccine produced from the strain
RECRUITING : Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
: Monkeypox
: 2024-11-21